ctDNA Predicts Pain Response in a Multi-Institutional Phase II Trial of Palliative Radiation, Palbociclib and Hormone Therapy in Metastatic Breast Cancer

被引：0

作者：

Torres, M. ^{[1
]}

Friend, S. ^{[2
]}

Niemierko, A. ^{[3
]}

Lin, J. Y. ^{[1
]}

Iafrate, A. ^{[3
]}

Xiao, C. ^{[4
]}

Kahn, S. T. ^{[5
]}

Godette, K. D. ^{[6
]}

Hanasoge, S. ^{[5
]}

Yu, D. S. ^{[6
]}

Eng, T. Y. ^{[5
]}

Cheney, M. D. ^{[7
]}

Wiggers, N. ^{[8
]}

Pippas, A. ^{[9
]}

Goginini, K.

Meisel, J. ^{[10
]}

Schuster, D. M. ^{[11
]}

Bardia, A. ^{[12
]}

Miller, A. H. ^{[13
]}

Felger, J.

Switchenko, J. ^{[14
]}

Zelnak, A. ^{[15
]}

Kalinsky, K. ^{[16
]}

Daniels, T. ^{[2
]}

Medford, A. ^{[3
]}

Bhave, M. ^{[17
]}

机构：

[1] Emory Univ, Glenn Family Breast Ctr, Winship Canc Inst, Atlanta, GA USA

[2] Emory Univ, Sch Med, Atlanta, GA USA

[3] Massachusetts Gen Hosp, Boston, MA USA

[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA

[5] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA

[6] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA

[7] Spectrum Healthcare Partners, Portland, ME USA

[8] Northside Hosp, Atlanta, GA USA

[9] Piedmont Columbus Reg, John B. Amos Canc Ctr, Columbus, GA USA

[10] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA USA

[11] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA

[12] UCLA, Los Angeles, CA USA

[13] Emory Univ, Sch Medi, Dept Psychiat & Behav Sci, Atlanta, GA USA

[14] Emory Univ, Atlanta, GA USA

[15] Northside Hosp, Atlanta Canc Care, Atlanta, GA USA

[16] Emory Winship Canc Inst, Atlanta, GA USA

[17] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1037

引用

页码：S164 / S164

页数：1

共 50 条

[1] Palliative Radiation Therapy for Breast Cancer With Skin Invasion: A Multi-institutional Prospective Observational Study
Nakamura, N.
Kawamori, J.
Takahashi, O.
Shikama, N.
Sekiguchi, K.
Takahashi, T.
Kato, S.
Ogita, M.
Haga, C.
Ito, R.
Nishimura, K.
Yamano, T.
Yoshida, K.
Motegi, A.
Akimoto, T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E524 - E524
[2] Phase II trial of palbociclib plus endocrine therapy followed by combination of pembrolizumab, palbociclib and endocrine therapy in patients with hormone receptor positive metastatic breast cancer
Yuan, Yuan
Egelston, Colt A.
Guo, Weihua
Yost, Susan E.
Frankel, Paul H.
Ruel, Christopher
Murga, Mireya
Tang, Aileen
Martinez, Norma
Schmolze, Daniel
Stewart, Daphne
Waisman, James
Yap, Kelly
Mortimer, Joanne
Tank, Niki
CANCER RESEARCH, 2023, 83 (05)
[3] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, Kyle E.
Kavanagh, Brian D.
Burri, Stuart H.
Chen, Changhu
Cardenes, Higinia
Chidel, Mark A.
Pugh, Thomas J.
Kane, Madeleine
Gaspar, Laurie E.
Schefter, Tracey E.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1579 - 1584
[4] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Rusthoven, Kyle E.
Kavanagh, Brian D.
Cardenes, Higinia
Stieber, Volker W.
Burri, Stuart H.
Feigenberg, Steven J.
Chidel, Mark A.
Pugh, Thomas J.
Franklin, Wilbur
Kane, Madeleine
Gaspar, Laurie E.
Schefter, Tracey E.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1572 - 1578
[5] A single arm phase II trial of Palbociclib in combination with Tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer
Danciu, Oana C.
Hoskins, Kent
Weiss, Jennifer
Truica, Cristina I.
Blaes, Anne
Tamkus, Deimante
Rana, Jatin
Pavankumar, Tandra
Green, Lauren
Gao, Yu
Yu, Menggang
Zhao, Qianqian
Toppmeyer, Deborah
O'Regan, Ruth
Wisinski, Kari B.
CANCER RESEARCH, 2023, 83 (05)
[6] A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and HormoneTherapy for Treatment of Bone Metastasis in Breast Cancer Patients
Torres, Mylin
Lin, Jolinta
Friend, Sarah
Xiao, Canhua
Cao, Yichun
Kahn, Shannon
Godette, Karen
Hanasoge, Sheela
Yu, David
Eng, Tony
Cheney, Matthew
Wiggers, Nancy
Pippas, Andrew
Gogineni, Keerthi
Meisel, Jane
Schuster, David
Bardia, Aditya
Miller, Andrew
Felger, Jennifer
Switchenko, Jeffrey
Zelnak, Amelia
Kalinsky, Kevin
Bhave, Manali
CANCER RESEARCH, 2024, 84 (09)
[7] Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial
Chang, Jee Suk
Kim, Sang Wun
Kim, Yeon-Joo
Kim, Joo-Young
Park, Sang-Yoon
Kim, Jin Hee
Jang, Tae-Kyu
Kim, Yong Bae
GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 39 - 45
[8] Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
Yuan, Yuan
Lee, Jin Sun
Yost, Susan E.
Frankel, Paul H.
Ruel, Christopher
Egelston, Colt A.
Guo, Weihua
Padam, Simran
Tang, Aileen
Martinez, Norma
Schmolze, Daniel
Presant, Cary
Ebrahimi, Behnam
Yeon, Christina
Sedrak, Mina
Patel, Niki
Portnow, Jana
Lee, Peter
Mortimer, Joanne
EUROPEAN JOURNAL OF CANCER, 2021, 154 : 11 - 20
[9] Results from the phase lb/II clinical trial of bazedoxifene and palbociclib in hormone receptor positive metastatic breast cancer
Jeselsohn, R.
Guo, H.
Rees, R.
Barry, W. T.
Barlett, C. H.
Tung, N. M.
Krop, I. E.
Brown, M.
Winer, E. P.
CANCER RESEARCH, 2019, 79 (04)
[10] A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Kaufman, DS
Carducci, MA
Kuzel, TM
Todd, MB
Oh, WK
Smith, MR
Ye, ZS
Nicol, SJ
Stadle, WM
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 393 - 397

← 1 2 3 4 5 →